Giant Cell Arteritis: all 173 studies
Page 1 of 2. Open to participants first (49), then studies with results posted, then the rest; newest registration first within each.
- Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular ResearchNot yet recruitingNCT07737470
- Kinetics of C-Reactive Protein in Giant Cell Arteritis Following Glucocorticoid Initiation: A Pilot Study (GIDEON)Not yet recruitingNCT07720804Not applicable
- Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study.Not yet recruitingNCT07628075Not applicable
- Disease Activity Monitoring in Patients With Giant Cell Arteritis StudyRecruitingNCT07552636
- Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCARecruitingNCT07508514
- Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia RheumaticaNot yet recruitingNCT07394478
- Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.Not yet recruitingNCT07354906
- Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)Not yet recruitingNCT07269938
- The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis.RecruitingNCT07246577
- Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell ArteritisRecruitingNCT07206238
- Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and EfficacyRecruitingNCT07150000
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell ArteritisRecruitingNCT07108387Phase 2
- Giant Cell Arteritis - Ways to Precision MedicineRecruitingNCT07084480
- Halo Sign Vanishing Time After Steroids Outbreak in GCA PatientsRecruitingNCT07060274Not applicable
- oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSoundRecruitingNCT07001059Not applicable
- Bosentan in the Treatment of Giant Cell ArteritisNot yet recruitingNCT06957002Phase 2
- Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell ArteritisRecruitingNCT06894602
- Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)RecruitingNCT06887062Phase 2
- Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of PrednisoneNot yet recruitingNCT06833411Phase 3
- A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.Not yet recruitingNCT06766552
- Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic DiseasesEnrolling by invitationNCT06763783Phase 4
- Performance of a Fast-track Pathway for Giant Cell Arteritis DiagnosisRecruitingNCT06742671
- AYLo - AutoimmunitY and Loss of yRecruitingNCT06696027
- Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)RecruitingNCT06609668
- Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia RheumaticaNot yet recruitingNCT06558357
- Visual Involvement in Giant Cell ArteritisRecruitingNCT06500728
- Assessing Biomarker in Giant Cell Arteritis and Polymyalgia RheumaticRecruitingNCT06460142
- A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel VasculitisRecruitingNCT06335888Phase 2
- Investigation of the Influence of the Human Microbiome on Giant Cell ArteritisRecruitingNCT06279065
- TocILizumab in aorTitis in GCA (TILT)RecruitingNCT06271018
- Clonal Hematopoiesis in Giant Cell ArteritisNot yet recruitingNCT06244069
- Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim)RecruitingNCT06004154
- DANIsh VASculitis Database (DANIVAS)RecruitingNCT05935709
- Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory DiseasesRecruitingNCT05904301
- Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)RecruitingNCT05865054
- Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)RecruitingNCT05854927
- Optic Nerve Sheath Ultrasound in Giant Cell ArteritisRecruitingNCT05749094
- Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell ArteritisRecruitingNCT05479448
- Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal InsufficiencyRecruitingNCT05435781Phase 4
- Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid TreatmentRecruitingNCT05193396Phase 4
- Abatacept for the Treatment of Giant Cell ArteritisRecruitingNCT04474847Phase 3
- Rheumatology Patient Registry and BiorepositoryRecruitingNCT04402086
- Expanded Access to UpadacitinibAvailableNCT04159597
- Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)RecruitingNCT04102930
- Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids TaperingRecruitingNCT04012905Phase 3
- VCRC Tissue RepositoryRecruitingNCT02967068
- Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic VasculitisRecruitingNCT02257866
- One-Time DNA Study for VasculitisRecruitingNCT01241305
- Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated VasculitisTerminatedNCT05168475Phase 2Results posted
- A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154TerminatedNCT04972968Phase 2Results posted
- A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell ArteritisTerminatedNCT04633447Phase 2Results posted
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).CompletedNCT03923738Phase 1Results posted
- KPL-301 for Subjects With Giant Cell ArteritisCompletedNCT03827018Phase 2Results posted
- A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell ArteritisCompletedNCT03765788Phase 2Results posted
- Tocilizumab Plus a Short Prednisone Taper for GCACompletedNCT03726749Phase 4Results posted
- A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell ArteritisCompletedNCT03725202Phase 3Results posted
- Assessment of Giant Cell Arteritis Medical Practices in FranceCompletedNCT03658889Results posted
- Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia RheumaticaTerminatedNCT03600818Phase 3Results posted
- Evaluation of Efficacy and Safety of Sarilumab in Patients With GCATerminatedNCT03600805Phase 3Results posted
- Baricitinib in Relapsing Giant Cell ArteritisCompletedNCT03026504Phase 2Results posted
- Ustekinumab for the Treatment of Giant Cell ArteritisTerminatedNCT02955147Phase 1/2Results posted
- Validation of a Diagnostic Algorithm of Giant Cell ArteritisCompletedNCT02703922Not applicableResults posted
- Efficacy and Safety Study of Sirukumab in Patients With Giant Cell ArteritisTerminatedNCT02531633Phase 3Results posted
- An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)CompletedNCT01791153Phase 3Results posted
- Tocilizumab for Patients With Giant Cell ArteritisCompletedNCT01450137Phase 2Results posted
- Study of Tocilizumab to Treat Polymyalgia RheumaticaCompletedNCT01396317Phase 2Results posted
- A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia RheumaticaTerminatedNCT01364389Phase 2Results posted
- Timed Release Tablet Prednisone in Polymyalgia RheumaticaCompletedNCT00836810Phase 2/3Results posted
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's ArteritisCompletedNCT00556439Phase 2Results posted
- TArget Trial Emulation Comparing Effectiveness of Tocilizumab vs Methotrexate In Corticosteroid-Treated GCA PatientsCompletedNCT07459335
- Cardiac Involvement in Patients With Giant Cell ArteritisCompletedNCT07031284
- A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)TerminatedNCT06281236Phase 1
- Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMRCompletedNCT06130540Phase 1
- TocilizuMab discontinuAtion in GIant Cell ArteritisActive, not recruitingNCT06037460Phase 3
- Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.CompletedNCT06011512
- The Applanation Tonometry in GCA PilotActive, not recruitingNCT05703763
- Melanocortin Gene Expression in Lymphocytes of Polymyalgia PatientsCompletedNCT05681676
- Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Patients With Suspected Giant Cell Arteritis (DOCTA)CompletedNCT05663333
- Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell ArteritisActive, not recruitingNCT05623592Phase 2
- CXCR4-PET/CT for Diagnosing Giant Cell ArteritisCompletedNCT05604482Not applicable
- Validation of the PMR Activity Score and Evolution of Patient-reported Outcomes in Patients With Polymyalgia RheumaticaCompletedNCT05542316
- A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)CompletedNCT05436652Phase 2
- Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical RemissionCompletedNCT05380453Phase 3
- Polymyalgia Rheumatica Associated to Primary Sjogren SyndromeStatus unknownNCT05312944
- Giant Cell Arteritis - Optimization of DiagnosticsCompletedNCT05248906
- Evaluation of PET/CT of Cephalic Arteries for the Diagnosis of Giant Cell ArteritisCompletedNCT05246540
- Pharmacogenetic Studies on Anti-IL-6 Receptor Monoclonal Antibodies on the Treatment of Rheumatic DiseasesStatus unknownNCT05045001
- FDG Digital PET/CT as First Line Investigation for Giant Cell ArteritisCompletedNCT05000138
- Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)CompletedNCT04930094Phase 3
- Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular InvolvementActive, not recruitingNCT04888221Phase 3
- Comparative Study of 3 Tocilizumab Products in Normal Healthy VolunteeersCompletedNCT04885829Phase 1
- Tofacitinib as a GC Sparing Agent for Polymyalgia RheumaticaCompletedNCT04799262Phase 2
- Immunopathology of Polymyalgia Rheumatica on Shoulder Bursae's BiopsiesCompletedNCT04727879Not applicable
- PRediction Of DIverse Glucocorticoids toxIcity OUtcomeSActive, not recruitingNCT04664465
- Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery BiopsyCompletedNCT04554290
- Improved Diagnostics and Monitoring of Polymyalgia RheumaticaActive, not recruitingNCT04519580
- Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in EuropeStatus unknownNCT04397237
- COVID-19 Related Lockdown Effects On Chronic DiseasesCompletedNCT04390126
- COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic DiseasesTerminatedNCT04335747